Mucosal prolapse in the pathogenesis of Peutz-Jeghers polyposis

M Jansen1, W W J de Leng, A F Baas

  • 1Academic Medical Centre of the University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands.

Gut
|December 14, 2005
PubMed

Insights

Peutz-Jeghers syndrome (PJS) polyps may form due to a genetic predisposition to epithelial prolapse. This hypothesis unifies observations of polyp formation and cancer risk in PJS patients.

Area of Science:

  • Gastroenterology
  • Oncology
  • Genetics

Background:

  • Peutz-Jeghers syndrome (PJS) is a rare disorder caused by germline mutations in the LKB1 gene.
  • The main characteristic of PJS is the development of gastrointestinal hamartomatous polyps.
  • While PJS polyps are typically considered non-premalignant, there's evidence of neoplastic changes and increased GI cancer risk in patients.

Purpose of the Study:

  • To propose a unifying hypothesis explaining the contrasting features of PJS polyposis.
  • To reconcile the generally accepted non-premalignant nature of PJS polyps with documented neoplastic changes and cancer risk.

Main Methods:

  • This study presents a hypothesis based on existing literature and observations.
  • The hypothesis integrates genetic predisposition, polyp formation, and cancer risk in PJS.

Main Results:

  • The hypothesis postulates that a genetic predisposition to epithelial prolapse underlies PJS polyp formation.
  • This mechanism explains the presence of hamartomatous polyps in PJS.
  • Sporadic adenomas in PJS patients are also hypothesized to exhibit mucosal prolapse and associated histological features.

Conclusions:

  • Epithelial prolapse offers a unifying explanation for PJS polyp characteristics.
  • This hypothesis helps resolve conflicting observations regarding the premalignant potential of PJS polyps.
  • The proposed mechanism may also apply to sporadic adenomas in PJS patients.

Related Concept Videos

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining. Bicarbonate,...
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Peptic Ulcer Disease I: Introduction01:25

Peptic Ulcer Disease I: Introduction

Peptic ulcer disease (PUD) involves breaks in the gastrointestinal tract's mucosal lining, primarily in the stomach and duodenum, with less frequent occurrences in the lower esophagus or near the pylorus.Ulcers can be acute or chronic. Acute ulcers are short-lived with minimal inflammation and heal quickly after the irritant is removed. Chronic ulcers persist, may recur, and often cause scarring due to ongoing tissue damage. Superficial erosions affect only the mucosal layer and are called...
Peptic Ulcer Disease II: Pathophysiology01:24

Peptic Ulcer Disease II: Pathophysiology

Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...